Regions Financial Corp’s Humacyte HUMA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.8K Hold
16,399
﹤0.01% 852
2026
Q1
$9.95K Hold
16,399
﹤0.01% 856
2025
Q4
$15.8K Hold
16,399
﹤0.01% 832
2025
Q3
$28.5K Hold
16,399
﹤0.01% 828
2025
Q2
$34.3K Hold
16,399
﹤0.01% 837
2025
Q1
$28K Hold
16,399
﹤0.01% 807
2024
Q4
$82.8K Buy
16,399
+4,226
+35% +$20.9K ﹤0.01% 806
2024
Q3
$66.2K Hold
12,173
﹤0.01% 822
2024
Q2
$58.4K Buy
+12,173
New +$63.4K ﹤0.01% 813

Other funds holding HUMA

Regions Financial Corp's HUMA Position: Q2 2026 in Review

Regions Financial Corp held its Humacyte (HUMA) position steady in Q2 2026 at 16,399 shares worth $12.8K. The position accounts for ﹤0.01% of the portfolio, ranked #852.

Regions Financial Corp first reported a position in HUMA in Q2 2024 and has held it in 9 quarters since. The position peaked at $82.8K in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Regions Financial Corp held 16,399 shares of Humacyte worth $12.8K as of Q2 2026.
  • Regions Financial Corp left its Humacyte share count unchanged in Q2 2026.
  • Humacyte made up ﹤0.01% of Regions Financial Corp's portfolio in Q2 2026, its #852 holding.
  • Regions Financial Corp first reported a position in Humacyte in Q2 2024 and has held it in 9 quarters since.
  • Regions Financial Corp's Humacyte position peaked at $82.8K in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Regions Financial Corp's 13F filing for Q2 2026, filed 10 Aug 2026.